$13.380
-0.878 (-6.56%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
GLUE Prediction & Forecast by Similar Chart Analysis
Alphio's GLUE stock price prediction model matches the current Monte Rosa Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $13.61 (+1.72%). The 1-week path is $13.45 (+0.49%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Monte Rosa Therapeutics Inc Stock?
Monte Rosa Therapeutics Inc (GLUE) is not a good buy right now. The current price is $13.38, and the RSI is at a low 24.659, indicating oversold conditions. The stock has seen a significant decline of 19.01% over the last 20 days and 12.61% year-to-date. Additionally, insider selling has increased by 122.61%, which raises concerns about confidence in the stock. The main risk is the recent downgrade in price targets by analysts, with Jefferies lowering its target to $25, which is below the current price.
GLUE stock price ended at $13.38 on Friday, after losing -6.56%
Monte Rosa Therapeutics Inc (GLUE) last closed at $13.38, losing -6.56%. These facts feed the 1-day and 1-week GLUE price prediction above.
Forecast Drivers
Monte Rosa Therapeutics Inc (GLUE) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches GLUE, ranked by similarity.
Seasonality analysis for GLUE
Historically the probability of a positive August return for GLUE is 31.75%. November offers the highest probability of a positive month at 100.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for GLUE
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.62 | $6.63 | $10.44 | -50.43% |
| Sep 2026 | $5.36 | $6.63 | $10.24 | -50.43% |
| Oct 2026 | $2.74 | $6.63 | $7.74 | -50.43% |
| Nov 2026 | $8.46 | $10.53 | $12.50 | -21.32% |
| Dec 2026 | $7.18 | $10.32 | $14.75 | -22.86% |
In 2026, Monte Rosa Therapeutics Inc (GLUE) is projected to range from $2.74 to $14.75.
Monte Rosa Therapeutics Inc 2026 monthly forecast
In Aug 2026, Monte Rosa Therapeutics Inc is projected to average $6.63, with a low of $3.62 and high of $10.44.
In Sep 2026, Monte Rosa Therapeutics Inc is projected to average $6.63, with a low of $5.36 and high of $10.24.
In Oct 2026, Monte Rosa Therapeutics Inc is projected to average $6.63, with a low of $2.74 and high of $7.74.
In Nov 2026, Monte Rosa Therapeutics Inc is projected to average $10.53, with a low of $8.46 and high of $12.50.
In Dec 2026, Monte Rosa Therapeutics Inc is projected to average $10.32, with a low of $7.18 and high of $14.75.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.